WallStSmart

GoHealth Inc. (GOCO) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

GoHealth Inc. stock (GOCO) is currently trading at $1.79. GoHealth Inc. PS ratio (Price-to-Sales) is 0.06. Analyst consensus price target for GOCO is $7.70. WallStSmart rates GOCO as Sell.

  • GOCO PE ratio analysis and historical PE chart
  • GOCO PS ratio (Price-to-Sales) history and trend
  • GOCO intrinsic value — DCF, Graham Number, EPV models
  • GOCO stock price prediction 2025 2026 2027 2028 2029 2030
  • GOCO fair value vs current price
  • GOCO insider transactions and insider buying
  • Is GOCO undervalued or overvalued?
  • GoHealth Inc. financial analysis — revenue, earnings, cash flow
  • GOCO Piotroski F-Score and Altman Z-Score
  • GOCO analyst price target and Smart Rating
GOCO

GoHealth Inc.

NASDAQFINANCIAL SERVICES
$1.79
$0.18 (-9.14%)
52W$1.31
$13.47
Target$7.70+330.2%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

GoHealth Inc. (GOCO) · 9 metrics scored

Smart Score

43
out of 100
Grade: D
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book, eps growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.

GoHealth Inc. (GOCO) Key Strengths (4)

Avg Score: 9.5/10
Price/SalesValuation
0.0610/10

Paying less than $1 for every $1 of annual revenue

Price/BookValuation
0.3610/10

Trading below book value, meaning the market prices it less than net assets

EPS GrowthGrowth
424.10%10/10

Earnings per share surging 424.10% year-over-year

Institutional Own.Quality
65.50%8/10

65.50% held by institutions, strong professional interest

Supporting Valuation Data

Price/Sales (TTM)
0.0591
Undervalued
EV/Revenue
0.901
Undervalued
GOCO Target Price
$7.7
304% Upside

GoHealth Inc. (GOCO) Areas to Watch (5)

Avg Score: 0.6/10
Return on EquityProfitability
-171.10%0/10

Company is destroying shareholder value

Operating MarginProfitability
-239.20%0/10

Losing money on operations

Revenue GrowthGrowth
-71.10%0/10

Revenue declining -71.10%, a shrinking business

Profit MarginProfitability
-27.00%0/10

Company is losing money with a negative profit margin

Market CapQuality
$44M3/10

Micro-cap company with very limited liquidity and high volatility

Supporting Valuation Data

Forward P/E
555.56
Expensive

GoHealth Inc. (GOCO) Detailed Analysis Report

Overall Assessment

This company scores 43/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.5/10) while 5 fall into concern territory (avg 0.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Price/Book, EPS Growth. Valuation metrics including Price/Sales (0.06), Price/Book (0.36) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 424.10%.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -71.10%, which may limit upside. Profitability pressure is visible in Return on Equity at -171.10%, Operating Margin at -239.20%, Profit Margin at -27.00%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -171.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -71.10% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

GOCO Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

GOCO's Price-to-Sales ratio of 0.06x trades at a deep discount to its historical average of 0.2x (20th percentile). The current valuation is 89% below its historical high of 0.53x set in Jul 2020, and 491% above its historical low of 0.01x in Sep 2022. Over the past 12 months, the PS ratio has compressed from ~0.2x as trailing revenue scaled faster than the stock price.

Compare GOCO with Competitors

Top INSURANCE BROKERS stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for GoHealth Inc. (GOCO) · FINANCIAL SERVICESINSURANCE BROKERS

The Big Picture

GoHealth Inc. is in a turnaround phase, with management focused on restoring profitability. Revenue reached 738M with 71% decline year-over-year. The company is currently unprofitable, posting a -27.0% profit margin.

Key Findings

Revenue Decline

Revenue contracted 71% YoY. Worth determining whether this is cyclical or structural.

Operating at a Loss

The company is unprofitable with a -27.0% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Volatility is elevated with a beta of 1.73, so expect amplified moves relative to the broader market.

Sector dynamics: monitor INSURANCE BROKERS industry trends, competitive moves, and regulatory changes that could impact GoHealth Inc..

Bottom Line

GoHealth Inc. is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About GoHealth Inc.(GOCO)

Exchange

NASDAQ

Sector

FINANCIAL SERVICES

Industry

INSURANCE BROKERS

Country

USA

GoHealth, Inc. is a health insurance marketplace and a Medicare-focused digital health company in the United States. The company is headquartered in Chicago, Illinois.